Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorazepam for Acute Pain in the ED
NCT03756038Phase 2Terminated
- Start
- Jan 2019
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lorazepam in acute pain. Started Jan 2019; status: terminated.
02
Drugs
lorazepam
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03756038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03756038.